MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
-39.38%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$323M
AUM Growth
+$323M
Cap. Flow
+$14.3M
Cap. Flow %
4.44%
Top 10 Hldgs %
99.66%
Holding
18
New
3
Increased
Reduced
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$183M 56.81% 5,831,253
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$52M 16.13% 5,681,544
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$28.9M 8.95% +2,168,691 New +$28.9M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$21M 6.5% 1,729,674
ELGX
5
DELISTED
Endologix Inc
ELGX
$9.38M 2.91% +1,121,447 New +$9.38M
NVRO
6
DELISTED
NEVRO CORP.
NVRO
$8.44M 2.62% 150,000
TARA icon
7
Protara Therapeutics
TARA
$120M
$7.61M 2.36% 983,381
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
$6.17M 1.91% 1,117,875
HSTO
9
DELISTED
Histogen Inc. Common Stock
HSTO
$2.55M 0.79% 1,192,080
AVTX icon
10
Avalo Therapeutics
AVTX
$122M
$2.22M 0.69% 595,436
SVRA icon
11
Savara
SVRA
$567M
$689K 0.21% 2,551,851
SGMO icon
12
Sangamo Therapeutics
SGMO
$157M
$136K 0.04% 22,487
CLCD
13
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$135K 0.04% 21,806
MGNX icon
14
MacroGenics
MGNX
$112M
$59K 0.02% 3,168
ALT icon
15
Altimmune
ALT
$338M
-6,347,614 Closed -$12.1M
TRIV
16
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
-1,776,692 Closed -$11.8M
ETRM
17
DELISTED
EnteroMedics Inc.
ETRM
-1,113,168 Closed -$145K